Mississauga, ON -- (SBWIRE) -- 01/30/2017 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled "Brainstorm Cell Therapeutics Starts Cryopreserved Trial"
Companies mentioned in this article include Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI).
Article Excerpt:
Stem cell therapies, despite their moral ambiguity, are gaining ground in the medical world. It is expected that the market for such therapies will be well over $300 million by 2020. The field is still in the nascent stage and therefore, the Pharmaceuticals companies engaging in such research are more prone to market and regulatory risks. However, the payoff in the case of success is also expected to be equally steep. One such potential winner in the field is Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI).
The company touched an important milestone as it announced early this morning that it has validated its cryopreservation process for NurOwn® in preparation for an upcoming Phase 3 clinical study in Amyotrophic Lateral Sclerosis (ALS).
The full version of this article can be found at:
http://www.allpennystocks.com/aps_us/special-reports/710/brainstorm-cell-therapeutics-starts-cryopreserved-trial.htm
About AllPennyStocks.com
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.
AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.
Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999.
Investors can receive their free newsletter subscription by clicking here:
http://www.allpennystocks.com/aps_common/newsletter_free.asp
Contact:
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: 905-361-5680
E-Mail: peter@allpennystocks.com
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com
Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp